Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 43 min ago
Peer-reviewedLicence not statedCurrent Opinion in Pharmacology

Gene therapies for RyR1-related myopathies

  • Isabelle Marty
  • Mathilde Beaufils
  • Julien Fauré
  • John Rendu
Open at sourceDOICite

Related

  1. Emerging Therapies for Genetic Deafness: The Rise of Precision Gene Editing
    Ghizlene Lahlou, Maxence Cornille, Nicolas Lai +2
    Ear & HearingPeer-reviewedCC BY-NC-ND 4.0Full textNeuroscienceHALPMC
  2. Population Frequency of RYR1 and CACNA1S Variants Associated with Malignant Hyperthermia in the Korean General Population: A KOVA Database Analysis
    Jihyo Byon, Jimyeong Jeong
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC
  3. Comparative transcriptome analysis of galls induced by four closely related aphid species using the draft genome of the host plant (Hamamelis japonica) reveals gene expression patterns related to gall diversification
    Mayu MIZUKI, Michiko SASABE, Hiroshi IKEDA
    BMC GenomicsPeer-reviewedCC BY 4.0Genetics & genomicsCrossref
  4. Neurobehavioral Profiles and Clinical Consequences of MYT1L-Related Neurodevelopmental Disorder: Insights from the Brain Gene Registry
    Jorge L. Granadillo, Levi Kaster, Virginia Lanzotti +11
    American journal of medical genetics. Part APeer-reviewedLicence not statedFull text2 citedGenetics & genomicsPMC
  5. Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign.
    Isabella Mullally, Eugene Smith, Peter Bedocs +5
    GenesPeer-reviewedCC BYFull textGenetics & genomicsEurope PMC

Cite

BibTeXRIS
BibTeX
@article{marty2026gene,
  title = {{Gene therapies for RyR1-related myopathies}},
  author = {Isabelle Marty and Mathilde Beaufils and Julien Fauré and John Rendu},
  journal = {Current Opinion in Pharmacology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.coph.2022.102330},
  url = {https://hal.science/hal-05788883v1},
}
RIS
TY  - JOUR
TI  - Gene therapies for RyR1-related myopathies
AU  - Isabelle Marty
AU  - Mathilde Beaufils
AU  - Julien Fauré
AU  - John Rendu
PY  - 2026
DA  - 2026/10/09
JO  - Current Opinion in Pharmacology
DO  - 10.1016/j.coph.2022.102330
UR  - https://hal.science/hal-05788883v1
SN  - 1471-4892
ER  -